Italy
Flamma, established in 1950, is a distinguished, family-owned, award-winning CDMO (Contract Development and Manufacturing Organization) with its headquarters situated near Milan, Italy. Operating in the Biotechnology, Manufacturing, and Pharmaceutical industries, Flamma has carved out a niche in the cGMP manufacturing of small molecule APIs, NCEs, RSMs, and advanced intermediates, particularly excelling in high-value chiral materials used in peptide drugs.
Flamma's extensive capabilities range from early-stage pre-clinical development in its Philadelphia facility to large-scale commercial manufacturing across three sites in Italy and one in Dalian, China. With over 1,000 employees and a combined production capacity of 1,300 m3, Flamma provides a comprehensive manufacturing solution for the entire life cycle of a small molecule drug.
Notably, Flamma has not listed any recent investments, implying a focus on stable growth and leveraging its longstanding industry reputation as The Thinking CDMO™.
